Idogen

Sweden
Lund, Skane Lan, Sweden
046 – 275 63 30 ★

Company profile

Idogen company profile

Idogen is a Swedish biotechnology company based in Lund. The Idogen share has been listed on Spotlight Stock Market since the 12th of June 2015 under the ticker IDOGEN and is traded through banks and stockbrokers. Idogen develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues. The term “tolerogenic” refers to the immune system’s selective tolerance of a specific pathogenic or immune activating antigen following treatment with Idogen’s therapy. Idogen’s intention is to revolutionise the treatment of several disorders in which the body’s immune system does..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
046 – 275 63 30
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2008-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Postal code
223 81
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $60.6K / 2020-03-31
Investors
1
Lead investors
1
Founders
1
Articles
24

Founders and investors

Founders

Lars Hedbys

Lead investors

Horizon 2020

Investors

Horizon 2020

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.